AbbVie pledges $100B to US production in drug pricing deal with Trump
Brad Rehnstrom2026-01-14T15:00:00+00:00
As with the many other “most-favored-nation” deals between the White House and large pharmas, the agreement is short on details as well as its potential financial impact.










